Last reviewed · How we verify

Paroxetine IR tablets A

GlaxoSmithKline · Phase 1 active Small molecule

Paroxetine IR tablets A is a Small molecule drug developed by GlaxoSmithKline. It is currently in Phase 1 development.

At a glance

Generic nameParoxetine IR tablets A
SponsorGlaxoSmithKline
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Paroxetine IR tablets A

What is Paroxetine IR tablets A?

Paroxetine IR tablets A is a Small molecule drug developed by GlaxoSmithKline.

Who makes Paroxetine IR tablets A?

Paroxetine IR tablets A is developed by GlaxoSmithKline (see full GlaxoSmithKline pipeline at /company/gsk).

What development phase is Paroxetine IR tablets A in?

Paroxetine IR tablets A is in Phase 1.

Related